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Translationally inactive histone mRNA is stored in frog oocytes, and translation is activated at oocyte
maturation. The replication-dependent histone mRNAs are not polyadenylated and end in a conserved stem-
loop structure. There are two proteins (SLBPs) which bind the 3* end of histone mRNA in frog oocytes. SLBP1
participates in pre-mRNA processing in the nucleus. SLBP2 is oocyte specific, is present in the cytoplasm, and
does not support pre-mRNA processing in vivo or in vitro. The stored histone mRNA is bound to SLBP2. As
oocytes mature, SLBP2 is degraded and a larger fraction of the histone mRNA is bound to SLBP1. The
mechanism of activation of translation of histone mRNAs may involve exchange of SLBPs associated with the
3* end of histone mRNA.
In the early development of many organisms, the major level
of gene regulation is translational. There is a “switch” from
translation of maternal mRNAs that are necessary for oogen-
esis and maintenance of the oocyte to translation of stored
maternal mRNAs that encode essential products for embryo-
genesis. At the time of translational activation there are a
number of modifications to the stored mRNP (reviewed in
reference 15). These modifications include cytoplasmic poly-
adenylation of selected mRNAs (35, 37, 38, 43, 47), which is
determined by a sequence, the cytoplasmic polyadenylation
element, in the 39 untranslated region (UTR) (11); modifica-
tion of the cap (19); and removal of proteins which inhibit
translation (25, 28, 45). Some or all of these modifications are
involved in the selective activation of translation of mRNAs at
oocyte maturation in the frog. The lengthening of the poly(A)
tail during oocyte maturation is an essential modification for
translation of the c-mos (14, 37) and cyclin mRNAs (38). The
poly(A) tail has been implicated in the recruitment of mRNAs
by the ribosome (18, 30), through an interaction of the poly(A)
binding protein with translation initiation factor eIF4G in yeast
(40, 41), or by interaction with other proteins that may form a
larger complex with the initiation factors (7).
Histone mRNAs are unique among metazoan mRNAs in
that they lack a poly(A) tail, ending instead in a conserved
stem-loop that fulfills many of the functions of the poly(A) tail
on other mRNAs (23). The stem-loop interacts with a specific
RNA-binding protein, termed the stem-loop binding protein
(SLBP), which participates in pre-mRNA processing (22, 46)
and remains associated with the mature histone mRNA as a
component of the polyribosomal histone mRNP (8, 16). The
stem-loop is essential for translation, presumably as a complex
with SLBP (13, 39).
A common feature of all embryos that have a rapid cleavage
stage is an extraordinary demand for histone proteins to incor-
porate into chromatin. In order to provide the necessary
amount of histone protein during early embryogenesis, there is
not the normal coupling of DNA replication and histone syn-
thesis. Instead histone mRNAs are stable and histone proteins
often are stored for later assembly into chromatin. The de-
mand for histone proteins increases exponentially as cleavage
proceeds. Thus, as much new histone must be incorporated
into chromatin as the embryo cleaves from 1,000 to 2,000 cells
as in the entire previous cleavage period. In the frog, all of the
histone mRNA (and 75% of the histone protein) to support
cleavage until the midblastula transition (MBT) (4,000 cells) is
stored in the oocyte (51, 52), since there is no transcription
until the MBT (31). After the MBT, there is active synthesis of
histone mRNA to supply additional templates for the synthesis
of new histones (42). Histone mRNA translation is activated at
oocyte maturation to provide the remaining 25% of the histone
protein needed prior to the MBT. The molecular basis of the
activation of histone mRNA translation is not known, nor is it
known how the histone mRNA is stored in an inactive form. It
is known that some of the stored histone mRNAs have short
oligo(A) tails (20, 34) that have been added to the stem-loop
(4). These oligo(A) tails are removed at oocyte maturation (4).
We report here that Xenopus oocytes have two SLBPs. One,
SLBP1, is the homologue of the mammalian SLBP present in
somatic cells. The other, SLBP2, is an oocyte-specific form.
SLBP2 is cytoplasmic, is present in high levels during early
oogenesis when histone mRNA is stored, and is destroyed
early in embryogenesis. In contrast, SLBP1 is present in low
levels in early oogenesis and increases in amount during late
oogenesis and early embryogenesis. It is likely that exchange of
the SLBPs bound to histone mRNA is part of the mechanism
of translational activation at oocyte maturation.
MATERIALS AND METHODS
Yeast three-hybrid screen. Four million transformants of Xenopus oocyte
cDNA cloned into pGAD10 were screened as described previously with the stem
loop sequence used as a bait (46). Plasmids were recovered from yeast that had
activated both the his3 and lacZ genes and tested for the ability to activate these
genes in yeast expressing a mutant stem-loop as the RNA bait (see Fig. 1A).
Those plasmids that did not activate the mutant stem-loop were sequenced, and
each encoded an SLBP. The complete sequence of the longest SLBP2 clone was
obtained at the University of North Carolina DNA Sequencing Facility.
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Treatment of oocytes with antisense oligonucleotides. A series of 12 oligonu-
cleotides (AX01 to AX12, each 15 nucleotides [nt]) were designed to hybridize
to the SLBP1 mRNA every 80 nucleotides, with the first, AX01, complementary
to a region in the 59 UTR and the last, AX12, complementary to a sequence in
the 39 UTR. The oligonucleotides were dissolved in 10 mM Tris–1 mM EDTA,
extracted with phenol-chloroform, precipitated with ethanol, and then resus-
pended in water at a concentration of 1 mg/ml. These oligonucleotides were
tested both for the ability to destroy SLBP1 mRNA and for toxicity to the oocyte.
Thirty nanoliters (30 ng) of each oligonucleotide was injected into the oocyte
cytoplasm. Four hours later, RNA was prepared, resolved by gel electrophoresis,
and assayed by Northern blotting with an SLBP1-specific probe. Injected oocytes
were also harvested at various times and cell lysates were assayed for SLBP by
mobility shift assay, using a radiolabeled stem-loop probe. The oligonucleotide
that destroyed SLBP1 mRNA and showed the least toxicity was AX03, which was
complementary to nt 457 to 471 of SLBP1 (accession no. U75681) (with the
initiator methionine at nt 1) and had the following sequence: 59-CATATCTTC
CTTCCTT. Oocytes were injected with AX09 and allowed to recover for 16 h
before subsequent injections with synthetic mRNAs. Injection of this oligonu-
cleotide did not affect U7 snRNA levels (data not shown).
Expression of proteins and characterization of antibodies. Glutathione S-
transferase (GST) fusion proteins were expressed after cloning of full-length
SLBP1 and SLBP2 into pGEX-KG. The SLBP1 fusion protein was purified on
glutathione-agarose. The SLBP2 fusion protein was present in inclusion bodies
and was solubilized in sodium dodecyl sulfate (SDS) and resolved by preparative
gel electrophoresis. The region containing SLBP2 was excised, and the gel was
ground up and injected into rabbits. Full-length SLBP1 and SLBP2 were also
expressed in baculovirus (Bac-to-Bac; GIBCO-BRL), and the resulting His-
tagged proteins were purified by chromatography on Ni-agarose. The baculovi-
rus-expressed SLBP2 protein was used to boost the rabbits that had been injected
with the GST fusion protein. Baculovirus-expressed SLBP1 was injected into
rabbits to prepare polyclonal antibodies. The SLBP2 antibodies were purified by
resolving the GST-SLBP2 fusion protein expressed in bacteria by SDS-polyacryl-
amide gel electrophoresis, transferring the protein to nitrocellulose, and then
incubating the serum with the nitrocellulose strip containing the GST-SLBP2
protein for 2 h at 4°C. The affinity-purified antibodies were eluted with 0.1 M
glycine at pH 2.8 and immediately neutralized. The antiserum to the complete
SLBP1 protein disrupted the RNA-protein complexes and also cross-reacted
weakly with the SLBP2 protein on Western blots. To further purify these anti-
bodies, a clone encoding an SLBP1-GST fusion protein with the RNA binding
domain deleted was constructed and the SLBP1 antibody was purified by binding
to this protein immobilized on nitrocellulose, followed by elution with 0.1 M
glycine-HCl, pH 2.8. Each of the affinity-purified antibodies detected a single
polypeptide by Western blotting and efficiently supershifted the appropriate
RNA-SLBP complexes. Polyclonal antibodies against the C-terminal 15 amino
acids of SLBP1 coupled to keyhole limpet hemocyanin were also prepared.
These antibodies did not recognize SLBP1 on Western blots and were useful only
for analyses of mobility shift assays.
Mobility shift assays. Frog oocytes of different stages were homogenized in 5
to 10 ml of 15 mM Tris (pH 7.0)–0.1 mM PMSF (phenylmethylsulfonyl fluoride)
per oocyte. Nuclei were manually dissected, and extracts were prepared from
nuclei and cytoplasm in the same buffer. The homogenate was extracted with
freon to remove the yolk (10). Similar results were obtained with extracts pre-
pared without freon extraction, although not as much protein could be analyzed
without affecting the resolution of the gel. Mobility shift and competition assays
were performed essentially as previously described with 10% polyacrylamide gels
(50).
Injection of oocytes. The SLBP1 and SLBP2 proteins were expressed at high
levels by injection of a synthetic capped mRNA transcribed from the respective
SLBPs cloned into a modified version of pSP64T (Promega), which contains the
59 and 39 UTRs of the human b-globin mRNA and a poly(A) tail (a gift of
Enrique Amaya and Doug Melton, Harvard University). To express histone
mRNAs, the mouse histone H2a-614 gene (15 nl, 30 ng/ml) was injected into frog
oocytes and RNA was prepared 18 h later (49). To assay for both processed and
unprocessed RNAs, a probe starting at the Sau3A site 163 nt from the 39 end of
the mRNA and extending 33 nt past the stem-loop was constructed, labeled at
the 39 end with [a-32P]dCTP, and used for S1 nuclease mapping. The processed
RNAs protect a 163-nt fragment, and the unprocessed RNAs protect a 196-nt
fragment. The protected fragments were resolved by polyacrylamide gel electro-
phoresis and quantified on a PhosphorImager.
Western blots. Oocytes were homogenized in a solution of 0.3 M KCl, 2 mM
MgCl2, 20 mM HEPES (pH 7.4), 0.5% Nonidet P-40 (NP-40), 20% glycerol, 2.5
mM dithiothreitol, and 0.1 mM PMSF (5 to 10 ml/oocyte). The homogenate was
centrifuged for 10 min at 14,000 rpm, and the clear supernatant was mixed with
an equal volume of 2% SDS–10% glycerol–0.06 M Tris (pH 6.8)–5% b-mercap-
toethanol and boiled; proteins from one to three oocytes were resolved by
electrophoresis on 12% SDS-polyacrylamide gels and transferred to nitrocellu-
lose. The filter was incubated with the affinity-purified antibody, and the bound
antibodies were detected by chemiluminescence with ECL technology (Amer-
sham).
In vitro processing. Nuclear extracts active in histone pre-mRNA processing
were prepared from mouse myeloma cells, as previously described (8, 24). To
remove the endogenous mouse SLBP, an antibody to the C-terminal peptide of
SLBP was incubated with 0.5 to 1.0 ml of nuclear extract for 2 h at 4°C. Twenty
microliters of protein A beads were added per 100 ml of extract. The beads were
precoated by incubation with nuclear extract at 4°C for 30 min prior to use. The
beads containing the bound antibody-SLBP complex were removed from the
extract by centrifugation.
To complement processing, 100 to 200 ng of purified baculovirus-expressed
protein encoding human SLBP, frog SLBP1, or frog SLBP2 was added to the
extract. The substrate used was derived from the histone H2a-614 gene with the
U7 snRNP binding site of the mouse histone H1t gene substituted for the U7
binding site of the H2a-614 gene (35a). Processing reaction mixtures were incu-
bated for 1 h at 32°C, and the RNA was prepared and analyzed by gel electro-
phoresis.
Histone mRNA immunoprecipitation. The histone mRNAs were precipitated
by a modification of the method developed recently in our laboratory (46a). Fifty
to 100 frog oocytes or eggs were homogenized (2 ml/oocyte) in a solution of 0.3
M KCl, 20 mM HEPES (pH 7.7), 2 mM MgCl2, 0.5% NP-40, 2.5 mM dithio-
threitol, 1 mM cycloheximide, 100 units of the protease inhibitor ACE per ml, 1
mM PMSF, and 100 U of RNasin per ml. The homogenate was centrifuged for
10 min at 14,000 rpm in a microcentrifuge, and the clear supernatant was used for
precipitation. An extract equivalent to five oocytes was incubated with affinity-
purified antibody (2.5 mg) and 1 U of additional RNasin per ml for 4 h to
overnight at 4°C on a rotator. Protein A beads (100 ml) were incubated with 200
ml of nuclear extract from blastula-stage sea urchin embryos (21). The precoated
beads were washed with buffer D (0.1 M KCl, 10 mM HEPES [pH 7.4], 0.1%
NP-40, 20% glycerol). Ten microliters of the precoated protein A beads and 30
ml of buffer D were added to the oocyte extracts, and the mixture was incubated
for 2 h at 4°C on a rotator. The beads were collected by centrifugation and
washed three times (5 min, 1 h, and 5 min) with 1 ml of buffer D. One hundred
microliters of 7 M urea, 2% SDS, 0.35 M NaCl, 10 mM EDTA, and 10 mM Tris
(pH 7.5) containing 10 mg of tRNA was added, the suspension was extracted
once with phenol-chloroform, and the RNA was recovered by precipitation with
ethanol. RNA was also prepared from the supernatant of the incubation with
protein A beads. The Xenopus histone H2a mRNA was detected with an S1
nuclease protection assay using a Xenopus H2a gene from a major histone gene
cluster (32) cloned from the oocyte cDNA library.
Northern blots. Total RNA was prepared from Xenopus oocytes and embryos,
as previously described (49). The RNA was treated with formaldehyde and
resolved on a 0.8% agarose gel, transferred to nitrocellulose, and hybridized with
a mixture of probes from SLBP1, SLBP2, and histone H3. The probes were
prepared by random primer labeling with [a-32P]dCTP. The specific activity of
the dCTP used to make the histone H3 probe was 1/20 of that of the dCTP used
to make the histone H3 probe.
Nucleotide sequence accession number. The complete nucleotide sequence of
the longest SLBP2 clone obtained in this study has been assigned accession no.
AF106799.
RESULTS
We previously reported the isolation of two orthologous
SLBPs from human (HeLa cell) and Xenopus oocyte two-
hybrid libraries (46) by using the yeast three-hybrid system
(36). We screened for proteins which bound the wild-type
stem-loop sequence in vivo but did not bind a mutant sequence
with the stem-loop reversed (Fig. 1A). We obtained multiple
isolates of the major SLBP from both human and Xenopus
libraries (46). However, one of the eight initial clones selected
from the Xenopus library encoded a protein different from the
major SLBP. Further analysis of this clone confirmed that it
passed the selection criteria (specific binding to the stem-loop
in yeast). Sequencing of this clone revealed that it encodes a
250-amino-acid polypeptide (Fig. 1B), which we have termed
SLBP2. SLBP2 has similarity to the major SLBP (46), which we
have now termed SLBP1, only in the 73-amino-acid RNA
binding domain (68% identity [Fig. 1C]). SLBP2, like SLBP1,
is small, about 28 kDa, and has its RNA binding domain
located in the central region of the protein.
Subsequent PCR analysis of the 30 clones we isolated from
the frog oocyte library with the three-hybrid screen revealed
that 23 encoded the homologue of the human protein (SLBP1)
and 7 encoded SLBP2. Like the SLBP1 clones, many of the
SLBP2 clones were fused to the Gal4 activation domain in the
59 UTR, in frame with the rest of the protein. Since the bac-
ulovirus-expressed SLBP2 and in vitro-translated SLBP2 have
electrophoretic mobilities similar to that of the SLBP2 we have
detected in Xenopus oocytes by Western blotting (not shown),
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we are confident that we have identified the entire open read-
ing frame. One of the clones we isolated had a poly(A) tail and
polyadenylation signal, suggesting that it was a near-full-length
clone. The size of this clone (1,066 nt) agrees well with the size
of the SLBP2 mRNA measured by Northern blots (see Fig.
5A).
Two complexes which bind the 3* end of histone mRNA are
present in Xenopus oocytes. To study the complexes containing
the different SLBPs which are present in Xenopus oocytes,
polyclonal antibodies were raised against both recombinant
SLBP1 and SLBP2 and were affinity purified to remove any
cross-reacting antibodies. Synthetic mRNAs encoding SLBP1
and SLBP2 were translated in a rabbit reticulocyte lysate.
SLBP1 has mobility similar to mammalian SLBP on SDS-
polyacrylamide gels (45 kDa), and SLBP2 has mobility of 35
kDa, close to the predicted molecular weight of 28 kDa (Fig.
2A). Specific complexes were formed with each in vitro trans-
lation product (Fig. 2B). The complex formed with SLBP1 has
mobility similar to the complex formed with the mammalian
SLBP (not shown), and the complex was supershifted by the
antibody against SLBP1 but not against SLBP2 (Fig. 2B, lanes
5 to 7). The SLBP2 in vitro translation product also bound the
stem-loop specifically (Fig. 2B, lanes 11 to 13) and reacted only
with the antibody against SLBP2 (Fig. 2B, lanes 9 and 10). The
complex formed with SLBP2 has lower mobility than the com-
plex formed with SLBP1 in both the reticulocyte lysate and in
frog oocyte extracts (see below).
Extracts were prepared from stage VI Xenopus oocytes, in-
cubated with a 30-nt radiolabeled stem-loop RNA, and then
analyzed by electrophoresis under native conditions. Two com-
plexes were detected in extracts from the whole oocyte (Fig.
2D, lane 1). Formation of both complexes was competed by the
wild-type stem-loop but not by the reverse-stem RNA (Fig. 2D,
lanes 2 and 3). To determine the subcellular localization of the
two activities, the oocytes were manually fractionated into nu-
cleus and cytoplasm. Complex x1 was present in both the nu-
clear and the cytoplasmic fractions, but complex x2 was found
exclusively in the cytoplasm (Fig. 2D, lanes 4 and 5). Antibod-
ies to SLBP1 specifically supershifted complex x1, and antibod-
ies to SLBP2 supershifted complex x2 (Fig. 2D, lanes 7 and 8).
We also measured the total amount (as compared to free
active SLBP) of each SLBP protein in the nucleus and cyto-
plasm by Western blotting with affinity-purified SLBP1 and
SLBP2 antibodies. SLBP1 was found in both the nucleus and
the cytoplasm (Fig. 2C, lanes 1 and 2), while SLBP2 was found
almost exclusively in the cytoplasm (Fig. 2C, lanes 3 and 4).
The small amount of SLBP2 in the nuclear fraction probably
results from slight contamination with cytoplasm.
To assess the relative affinities of the two SLBPs for the
stem-loop, we performed competition experiments with frog
extracts that contained both SLBP1 and SLBP2 binding activ-
ity. Two types of assays were performed (Fig. 2E). When the
assay was performed in probe excess and varying amounts of
the wild-type competitor were added to the extract, formation
of both complexes was competed to a similar extent at all
concentrations of competitor (Fig. 2E, lanes 2 to 6). In the
second assay, increasing amounts of probe were added to the
FIG. 1. Isolation of SLBP2. (A) Wild-type (WT) and mutant (RM) stem-
loop sequences used in the yeast three-hybrid selection and RNA binding ex-
periments reported in this paper. (B) Complete nucleotide sequence of the
longest SLBP2 clone. The putative polyadenylation signal is underlined. (C)
Comparison of the protein sequences of SLBP1 and SLBP2. The RNA binding
domains of the two SLBPs are shown in boldface type and underlined. Vertical
lines indicate identical amino acids, and double dots indicate similar amino acids.
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extract to determine whether one SLBP bound preferentially
to limiting amounts of probe. As increasing amounts of probe
were added, the amounts of complex x1 and x2 increased in
parallel (Fig. 2E, lanes 7 to 9). Taken together, these results
demonstrate that SLBP1 and SLBP2 have similar affinities for
the stem-loop.
SLBP1, not SLBP2, functions in histone pre-mRNA pro-
cessing. To determine whether both SLBP1 and SLBP2 can
function in histone pre-mRNA processing, we expressed both
SLBP1 and SLBP2 from baculovirus vectors, and tested the
ability of the recombinant proteins to participate in pre-
mRNA processing in vitro. Both of the baculovirus proteins
bound to the stem-loop with similar affinity (Fig. 3A). A nu-
clear extract highly active in pre-mRNA processing was pre-
pared from mouse myeloma cell nuclei, as previously described
(8, 24). The mouse SLBP was removed from this extract by
using an antibody against the C-terminal peptide and protein
A-agarose. The depleted extract is inactive in pre-mRNA pro-
cessing (Fig. 3B, lane 3), while a mock-depleted extract re-
tained most of its initial activity (Fig. 3B, lanes 1 and 2).
Recombinant mouse SLBP, frog SLBP1, and frog SLBP2 ex-
pressed in baculovirus were added back to the extract. Mouse
SLBP and frog SLBP1 restored processing to normal levels
(Fig. 3B, lanes 4 and 5), demonstrating that the only compo-
nent necessary for processing depleted by the antibody was
SLBP. Frog SLBP2 was totally inactive in pre-mRNA process-
ing (Fig. 3B, lane 6) even though it bound the stem-loop (Fig.
3A, lane 4).
We also tested the ability of the two Xenopus SLBPs to
complement histone pre-mRNA processing in vivo. Injection
of antisense oligonucleotides into Xenopus oocytes results in
degradation of the target mRNAs by RNase H and then sub-
sequent degradation of the injected oligonucleotide (17). Of-
ten there is also reduction of the levels of the encoded protein
as a result of destruction of the mRNA (17). We tested several
antisense oligonucleotides against SLBP1 for the ability to
FIG. 2. Two complexes are formed on the stem-loop in Xenopus oocytes. (A) Clones encoding SLBP1 (lane 1) and SLBP2 (lane 2) were transcribed in vitro and
then translated in a rabbit reticulocyte lysate in the presence of [35S]methionine. The products were resolved by electrophoresis on an SDS–12% polyacrylamide gel
and detected by radioautography. (B) Reticulocyte lysates programmed with either SLBP1 (lanes 2 to 8) or SLBP2 (lanes 9 to 13) mRNAs were incubated with the
radiolabeled probe containing the stem-loop, and the complexes were resolved by gel electrophoresis. The antibody to the C-terminal peptide of SLBP1 was added in
lanes 5 to 7 and lane 9. The SLBP1 antibody was preincubated with the antigenic peptide in lane 6 and with control peptide from the N terminus of SLBP1 in lane
7. The affinity-purified antibody to SLBP2 was added in lanes 8 and 10. A 100-fold excess of competitor unlabeled RNAs containing the stem-loop (WT) (lanes 3 and
12) or the reverse-stem (RS) (lanes 4 and 13) sequence was added to some reaction mixtures. (C) Oocytes were fractionated into nuclei and cytoplasm, and proteins
from three oocytes were resolved by SDS-polyacrylamide gel electrophoresis. The gel was transferred to nitrocellulose and probed with affinity-purified anti-SLBP1
(lanes 1 and 2) or anti-SLBP2 (lanes 2 and 3) antibodies. (D) Total extracts from frog oocytes were incubated with the wild-type stem-loop probe (lanes 1 to 3 and
6 to 8). A 100-fold excess of unlabeled reverse-stem RNA (RS) (lane 2) or wild-type RNA (WT) (lane 3) was included as competitor. The oocytes were fractionated
into nuclei (lane 4) and cytoplasm (lane 5). Affinity-purified polyclonal antibodies to SLBP1 (a-X1) (lane 7) or SLBP2 (a-X2) (lane 8) were added to the reaction
mixture. The complexes formed with SLBP1 and SLBP2 are denoted x1 and x2, respectively, and the supershifted complexes are denoted SP (lanes 7 and 8). (E) An
extract from stage IV oocytes was incubated with the radiolabeled probe and increasing molar amounts of stem-loop competitor (lanes 2 to 6), and the complexes were
resolved by gel electrophoresis. A similar extract from stage III oocytes was incubated with increasing amounts of radiolabeled probe (lanes 7 to 9), and the complexes
were resolved by gel electrophoresis.
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destroy SLBP1 mRNA. Many of these resulted in complete
cleavage of the SLBP1 mRNA (Fig. 4A, lanes 1 to 8), while a
control oligonucleotide had no effect on SLBP1 mRNA (Fig.
4A, lane 13). One of these oligonucleotides, AX09 (Fig. 4A,
lane 3), also showed minimal toxicity to the oocytes and was
used for the subsequent studies. Extracts were prepared from
oocytes 48 h after injection of antisense oligonucleotide AX09.
These extracts had greatly reduced amounts of free active
SLBP1 protein but the same amount of free active SLBP2
protein as control oocytes or oocytes injected with a control
oligonucleotide (Fig. 4B). Thus, the antisense treatment selec-
tively removed the SLBP1 protein.
We then demonstrated that the levels of SLBP1 could be
restored by injection of synthetic SLBP1 mRNA. In order to
complement the oocytes deficient in histone pre-mRNA pro-
cessing, we expressed the SLBP1 and SLBP2 proteins in the
oocyte by injecting mRNAs encoding either SLBP1 or SLBP2.
In each case, a large amount of active SLBP was expressed as
judged by a mobility shift assay. Expression of either SLBP
from injected mRNA resulted in a 20- to 30-fold increase in
SLBP over the amount already present in the mature oocyte
(Fig. 4C), and overexpressed SLBP1 and SLBP2 had the same
subcellular distributions as endogenous SLBP1 and SLBP2 (cf.
Fig. 4C and Fig. 2C and D).
To determine whether the reduction in free SLBP1 protein
resulted in a reduction in the ability to process histone mRNA,
we developed an S1 nuclease protection assay that allowed us
to measure both processed and unprocessed mRNA from an
injected mouse histone gene (Fig. 4D). This assay maps both
the properly processed RNA and any transcripts which extend
more than 33 nt past the 39 end of histone mRNA. These
heterogeneous longer transcripts all protect the same size frag-
ment. The ratio of the two protected fragments is a measure of
the efficiency of processing. When a control oligonucleotide
was injected into the oocytes prior to injection of the mouse
histone H2a-614 gene, the majority (70 to 80%) of the tran-
scripts were processed (Fig. 4D, lane 1). When the oocytes
were injected with antisense oligonucleotide AX03 prior to
injection of the H2a-614 gene, reducing the amount of free
SLBP1, the processing efficiency was reduced to about 35%
(Fig. 4D, lane 2). Expression of SLBP1, but not SLBP2, by
injection of the appropriate synthetic mRNA restored process-
ing to .80% efficiency in vivo (Fig. 4D, lane 4).
We also injected mRNAs encoding either SLBP1 or SLBP2
into oocytes that had not been injected with antisense oligo-
nucleotides. After 48 h, to allow expression of SLBP, the
mouse histone H2a-614 gene was injected into the oocyte nu-
cleus, and RNA was prepared from the oocytes 16 h later. This
batch of oocytes processed about 80% of the histone tran-
scripts, as did oocytes injected with the SLBP2 mRNA (Fig.
4D, lanes 5 and 6). Oocytes injected with the SLBP1 mRNA
processed .95% of the histone transcripts (Fig. 4D, lane 7).
Thus, both of these experiments demonstrate that SLBP1, but
not SLBP2, functions in histone pre-mRNA processing in vivo.
Differential expression of SLBP1 and SLBP2 during devel-
opment. We used Northern blots, mobility shift assays, and
Western blots to measure the expression of SLBP mRNAs and
protein during oogenesis and embryogenesis. Northern blots
were done to compare the levels of histone H3 mRNA, SLBP1
mRNA, and SLBP2 mRNA. SLBP1 is encoded by an mRNA
which is 6 to 7 kb long (the largest cDNA clone we obtained
was 4.5 kb), SLBP2 is encoded by a 1.3-kb mRNA, and histone
H3 is encoded by a family of mRNAs about 500 nt in length.
Therefore, we were able to resolve these three mRNA species
by hybridizing a single blot with all three probes. The specific
activity of the probe for histone mRNA was deliberately made
20 times lower than the two SLBP probes, which were of
similar specific activities, to allow the abundant histone mRNA
to be readily detected on the same blot. Some histone mRNA
was already present in stage I oocytes, and it reached a con-
stant level by stage III (Fig. 5A). There was no further increase
in histone mRNA until the MBT (Fig. 5A), when transcription
is activated, as previously reported (42). SLBP1 mRNA and
SLBP2 mRNA are expressed in stage I oocytes and reach
constant levels by stage III of oogenesis. SLBP1 mRNA re-
mains present at the same level in early embryogenesis, and the
amount of SLBP1 mRNA increases after the MBT. In con-
trast, SLBP2 mRNA is destroyed by the MBT (Fig. 5A, stages
7 and 9) and is not expressed later in embryogenesis or in
somatic cells (not shown).
To measure the relative amounts of the SLBP1 and SLBP2
proteins, extracts were prepared from the six stages of oogen-
esis and several embryonic stages and assayed by mobility shift
assay (Fig. 5B) and Western blotting (Fig. 5C). The mobility
shift assay measures soluble, active SLBP. It may not detect
SLBPs that are tightly complexed with RNA (16) and will not
detect any SLBPs that exist in modified forms which do not
bind RNA with high affinity. There were higher levels of
SLBP2 binding activity than of SLBP1 binding activity in stage
I oocytes, and these high ratios persisted through stage III of
FIG. 3. SLBP1, but not SLBP2, functions in histone pre-mRNA processing in
vitro. (A) SLBP1, SLBP2, and human SLBP (hSLBP) were expressed in bacu-
lovirus, and 200 ng of protein was analyzed for binding to the stem-loop by
mobility shift assay. (B) A 291-nt substrate was synthesized with T7 RNA poly-
merase from the mouse histone H1t gene. A nuclear extract prepared from
mouse myeloma cells was very active in histone pre-mRNA processing (lane 1).
The extract was depleted by using an antibody to the C terminus of mouse SLBP
(lane 3), or was treated with immunoglobulin G purified from preimmune serum
(lane 2). An equal amount (200 ng) of recombinant baculovirus-expressed mouse
SLBP (M) (lane 4), frog SLBP1 (X1) (lane 5), or SLBP2 (X2) (lane 6) was added
to the depleted extract. The extracts were incubated for 30 min at 27°C, and
RNA was prepared and analyzed by electrophoresis on 8% polyacrylamide–7M
urea gels.
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oogenesis (Fig. 5B). Later in oogenesis (stages IV to VI), the
amount of SLBP1 activity was higher than the amount of
SLBP2 activity, due largely to an increase in the amount of
active SLBP1, although there was also a decrease in the
amount of active SLBP2 (Fig. 5B). In eggs and early embryos,
there was very little SLBP2 activity and large amounts of
SLBP1 activity (Fig. 5B). Note that in these assays, which are
done in probe excess, we measure the actual relative amounts
of free active SLBP1 and SLBP2 protein, since they bind the
stem-loop with similar affinities (Fig. 2D).
Qualitatively similar results were obtained when total
SLBP1 and SLBP2 protein were measured by Western blot-
ting. We assayed total protein from equal numbers of oocytes
from different stages. SLBP2 was readily detectable in stage I
oocytes and increased through stages III and IV. There was a
subsequent slight decline in SLBP2 levels as oocytes matured
FIG. 4. SLBP1, but not SLBP2, is involved in histone pre-mRNA processing. (A) A series of antisense oligonucleotides (AX07 to AX12, lanes 1 to 6; AX01 to AX06,
lanes 7 to 12) directed against SLBP1 mRNA were injected into Xenopus oocytes, and RNA was prepared 4 h later. The RNA was resolved by electrophoresis on a
0.8% agarose gel and probed for SLBP1 mRNA. (B) Oocytes were injected with oligonucleotide AX09 and a control oligonucleotide, and extracts were prepared 48 h
later. The extracts were assayed by mobility shift assay for the formation of complexes that bind to the stem-loop. (C) Oocytes were injected with synthetic mRNAs
encoding SLBP1 (lanes 2 and 3) or SLBP2 (lane 3 and 4). Forty-eight hours later, the oocytes were fractionated into nuclei and cytoplasm and assayed for the presence
of complexes that bound the stem-loop. Lane 1 shows an extract from uninjected oocytes. Extracts from one oocyte were analyzed in each lane. (D) Oocytes were
injected with oligonucleotide AX09 (lanes 2 to 4) or with a control oligonucleotide (lane 1). Four hours later, synthetic mRNA encoding SLBP2 (lane 3) or SLBP1
(lane 4) was injected into some of the oocytes. After 48 h, histone H2a-614 DNA was injected into the nucleus. RNA was prepared 18 h after the injection of H2a-614
DNA, and the transcripts were assayed for processed and unprocessed histone mRNA by using an S1 nuclease assay, as shown at the bottom. In a separate experiment,
untreated oocytes were injected with buffer (lane 5) or mRNAs encoding frog SLBP2 (lane 6) or frog SLBP1 (lane 7) 48 h prior to injection of histone H2a-614 DNA
into the nucleus. RNA was prepared 18 h after injection of the DNA and analyzed by using S1 nuclease mapping.
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to stage VI (Fig. 5C, bottom). The levels of SLBP2 protein
dropped dramatically in eggs compared to stage VI oocytes,
indicating that most of the SLBP2 is degraded in the transition
from oocytes to eggs. SLBP2 was also degraded when oocytes
were matured in vitro by treatment with progesterone (Fig. 5C,
lane P). In contrast, the levels of SLBP1 were very low in stage
I oocytes and gradually increased throughout oogenesis (Fig.
5C, top). There was a further twofold increase in SLBP1 when
the oocytes were matured to eggs (Fig. 5C). The levels of
SLBP1 continued to increase during early embryogenesis (not
shown).
Although the results of the Western blot and mobility shift
assays were qualitatively similar, there were significant quan-
titative differences. Western blotting measures all of the SLBP
protein, while the mobility shift assay measures the amount of
free active protein. First, there is a large increase in the SLBP1
activity measured by the mobility shift assay at stage IV of
oogenesis. In contrast, there is a gradual increase in SLBP1
protein from stages II to V of oogenesis, as analyzed by West-
ern blotting. These results are consistent with some SLBP1
being released from histone mRNA or becoming activated
between stage III and stage IV of oogenesis. Second, there is
not a dramatic decrease in the amount of free SLBP2 binding
activity as oocytes are matured to eggs, as measured by the
mobility shift assay, while there is a dramatic drop as measured
by Western blotting. This result suggests that much of the
SLBP2 protein in stage VI oocytes is either bound to histone
mRNA or is in an inactive form. These results are consistent
with the accumulation of free SLBP1 late in oogenesis, while
most of the SLBP2 is bound to stored histone mRNA. At
oocyte maturation, the degradation of SLBP2 may then allow
SLBP1 to associate with the histone mRNA.
Different SLBPs are associated with histone mRNA during
different developmental stages. To determine which SLBPs
were associated with histone mRNAs at each stage of oogen-
esis, we used antibodies to the two SLBPs to precipitate com-
FIG. 5. Expression of SLBP1 and SLBP2 during oogenesis and early embryogenesis. (A) RNA was prepared from oocytes and early embryos and resolved by gel
electrophoresis on a 1% agarose gel. RNA from two oocytes or embryos was analyzed. The gel was transferred to nitrocellulose and hybridized with a mixture of probes
to SLBP1, SLBP2, and histone mRNA. The histone probe was made at one-half of the specific activity of the other two probes. The identity of the bands was confirmed
by hybridizing with single probes. (B) Extracts were prepared from oocytes and embryos and assayed for SLBP1 and SLBP2 by mobility shift assay. Each lane is analysis
of one oocyte. (C) Protein from one oocyte (top) or four oocytes (bottom) was analyzed by Western blotting with either affinity-purified anti-SLBP1 (top) or
affinity-purified anti-SLBP2 (bottom). Lanes P show oocytes matured by treatment with progesterone, and lanes E show eggs. The apparent higher mobility of SLBP1
in eggs in this experiment was not seen in other experiments.
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plexes containing the SLBPs from oocyte and egg extracts.
RNA was prepared from the antibody precipitates and the
histone H2a mRNA detected by S1 nuclease mapping of the
bound and unbound mRNAs. A portion of the unbound frac-
tion was analyzed by Western blotting to demonstrate that the
SLBPs had indeed been removed from the extracts (not
shown). In each experiment we performed the precipitations
with each extract with the three antibodies (SLBP1, SLBP2,
and mouse SLBP) in parallel. The absolute amounts of the
histone mRNA precipitated varied some from experiment to
experiment, but the relative amounts precipitated by anti-
SLBP1 and anti-SLBP2 were similar for extracts from the same
stage in different experiments. When stage IV or VI oocytes
were analyzed, very little histone H2a mRNA was precipitated
by anti-SLBP1. In stage II oocytes, about twice as much histone
mRNA was precipitated by anti-SLBP2 as by anti-SLBP1 (Fig.
6, lanes 1 and 5). More than 70% of the histone H2a mRNA
was precipitated by anti-SLBP2 in stage IV oocytes (Fig. 6,
lanes 6), and less than 10% was precipitated by anti-SLBP1. In
stage VI oocytes, three times as much histone mRNA was
precipitated by the SLBP2 antibody as the SLBP1 antibody,
even though most of the SLBP present in stage VI oocytes is
SLBP1. Thus, throughout oogenesis, the bulk of the histone
mRNA is associated with SLBP2. Since in both stage IV and
stage VI oocytes the most abundant free SLBP is SLBP1 (Fig.
5B), while most of the histone mRNA isolated by antibody
precipitation is bound to SLBP2, it is unlikely that there has
been significant rearrangement of the SLBPs during the isola-
tion and precipitation procedures.
When eggs were analyzed by an identical procedure using
the same two antibodies, the results were strikingly different.
More histone mRNA was precipitated by the anti-SLBP1 an-
tibody than by the anti-SLBP2 antibody (Fig. 6, lanes 14 and
16). Essentially identical results were obtained when extracts
from oocytes matured by treatment with progesterone in vitro
were analyzed (Fig. 6, lanes 4 and 8). During this period, there
is a dramatic decrease in the total amount of SLBP2 protein
measured by Western blotting (Fig. 5C). Thus, during the
transition from an oocyte to an egg, much of the histone
mRNA loses its SLBP2 protein and then binds to SLBP1 (Fig.
7), and the SLBP2 protein is degraded. This transition occurs
at the time of activation of histone mRNA translation (51),
suggesting that this is one of the molecular events involved in
translational regulation.
DISCUSSION
Early in oogenesis, the frog stores most of the maternal
mRNAs which will be utilized in early embryogenesis. Storage
of mRNAs occurs concomitantly with the biosynthesis of the
mRNA, and some of the essential events, including association
with the general translational repressor FRGY2, require that
the RNA be synthesized in the nucleus (6, 26, 29). The stored
inactive mRNAs generally have short poly(A) tails (47). Other
mRNAs that are translated in oocytes have longer poly(A) tails
and are presumably not complexed with FRGY2 or other
translational repressors. At oocyte maturation, a translational
program is activated (48) which controls development until the
MBT, when zygotic transcription is activated (31). This pro-
gram involves default deadenylation of the majority of mRNAs
(12) and selective cytoplasmic adenylation of many RNAs that
are then translated (5, 15). In addition, there are general and
FIG. 6. Determination of SLBPs bound to histone mRNA during oogenesis. Extracts from stage II (lanes 1, 5, and 9), stage IV (lanes 2, 6, and 10), and stage VI
(lanes 3, 7, 11, 13, 15, and 17) oocytes, oocytes matured in vitro with progesterone (lanes 4, 8, and 12), or eggs (lanes 14, 16, and 18) were incubated with antibodies
to either frog SLBP1 (lanes 1 to 4, 13, and 14), frog SLBP2 (lanes 5 to 8, 15, and 16), or mouse SLBP (lanes 9 to 12, 17, and 18). The RNAs bound to the antibodies
were isolated and assayed by S1 nuclease mapping for frog histone H2a mRNA (top). RNA was also prepared from the supernatant after incubation with antibody and
protein A-agarose and assayed for frog histone H2a mRNA by S1 nuclease mapping (bottom). The protected fragments were resolved by gel electrophoresis and
detected by autoradiography. The results are representative of three independent experiments. A diagram of the S1 nuclease assay is shown. The mRNA from this H2a
gene protects a 224-nt fragment (H2a), and the mRNAs from other H2a genes protect a 180-nt fragment (H2ax) which maps to the stop codon.
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sequence-specific RNA binding proteins that are involved in
translational repression, which must also be removed from
mRNAs at this time (15). Similar programs of translational
control are present in many early embryos (15, 44, 48).
A fraction of the frog oocyte histone mRNA binds to oli-
go(dT) cellulose (20, 34) due to a small number of adenosines
added to the end of the stem-loop (4). These terminal ad-
enosines are removed at oocyte maturation (4). However, only
a small fraction of the stored histone mRNAs with stem-loops
in stage VI oocytes are polyadenylated, as judged by binding to
oligo(dT) cellulose (35b). This modification does not affect the
relative affinity of the two different SLBPs (45a), and hence
this modification cannot be essential for the global activation
of histone mRNA translation.
In organisms with very rapid cleavage stages, there is an
exponentially increasing demand for histone proteins to assem-
ble chromatin as development proceeds. Many different strat-
egies have evolved for dealing with this problem. Some organ-
isms (e.g., sea urchins) have a set of histone genes that are
present in multiple copies and are expressed only during the
rapid cleavage stages (27). These zygotic genes supply histone
mRNAs during the cleavage stages and then are not used
again. In Drosophila, there is stored histone mRNA utilized
initially as well as synthesis of histone mRNA from a set of
repeated genes (2, 3).
Since there is no transcription in frog embryos until the
MBT (approximately 4,000 cells), the frog embryo must rely
solely on stored histone protein and increased histone mRNA
translation to supply the histones necessary to assemble chro-
matin prior to the MBT. Histone synthesis is translationally
regulated in early frog embryos. During oogenesis, there is
synthesis of histones in stages II and III of oogenesis and then
a decrease to a very low level in oocyte stages IV to VI (51).
There is a 17-fold increase in the rate of histone protein syn-
thesis at oocyte maturation (1, 51). Adamson and Woodland
(1) showed that the increase in histone mRNA translation is
greatly reduced in enucleated oocytes, suggesting that some
component in the nucleus is necessary for activation of trans-
lation of histone mRNA, as it is for regulation of polyadenyl-
ation of other oocyte mRNAs (11). There is a further increase
in the translation rate during early development, prior to the
increase in histone mRNA levels after the MBT, resulting in an
ultimate 50-fold increase in the rate of histone protein synthe-
sis (51). The same histone mRNAs are expressed in oogenesis,
during early development, and in somatic cells (33). Since
histone mRNAs are not polyadenylated, they must be transla-
tionally regulated by a mechanism distinct from the regulation
of polyadenylated mRNAs. The different SLBPs are likely can-
didates to play a key role in this translational regulation, and
SLBP2 may be a protein that has evolved as a specific trans-
lational repressor.
The 39 end of histone mRNA is essential for association of
the mRNA with polyribosomes (39) and translation of histone
mRNA (13) in mammalian cells. Since the mammalian homo-
logue of the SLBP1 is a component of the histone mRNP (16),
frog SLBP1 is probably associated with the translationally ac-
tive histone mRNA. There is synthesis of histone protein dur-
ing stage II of oogenesis and a lower rate of synthesis in mature
oocytes (51, 52). During stage II of oogenesis, the oocyte syn-
thesizes about 75% of the histone protein necessary for early
cleavage over a period of at least 1 to 2 weeks (9). The other
25% of the histone protein is synthesized from stored maternal
FIG. 7. Model for histone mRNA metabolism during oogenesis in Xenopus.
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RNA in a few hours. Only a small proportion of the total
histone mRNA would be required for production of the his-
tone protein in stage II oocytes. It is possible that a fraction of
the histone mRNA synthesized in stage II remains associated
with SLBP1 and is translated while the remainder of the his-
tone mRNA associates with SLBP2 and is stored.
In support of this possibility, we have found a larger pro-
portion of histone mRNA bound to SLBP1 in stage II oocytes
than in stage IV oocytes (Fig. 6). Early in oogenesis, when
histone mRNA is synthesized, the histone mRNA must be
processed by SLBP1 and subsequently associate with SLBP2
(Fig. 7). A fraction of the histone mRNAs may remain asso-
ciated with SLBP1 and be translated in stage II, while the rest
is transferred to SLBP2 and is stored. Alternatively, all of the
histone mRNAs may be translated for some time prior to
association with SLBP2, resulting in storage. There is probably
not sufficient SLBP1 to associate with all of the histone mRNA
in stage II, implying that SLBP1 may function essentially cat-
alytically rather than stoichiometrically during this stage. By
stage IV of oogenesis, accumulation of histone mRNA has
ceased and the great majority of the histone mRNA is bound
to SLBP2. Once bound to SLBP2, the histone mRNA remains
bound to SLBP2 and is translationally inactive throughout the
remainder of oogenesis, even while the oocyte accumulates
large amounts of SLBP1 protein. At oocyte maturation, there
is a loss of SLBP2 from much of the histone mRNA, the
histone mRNA is then bound by SLBP1, and SLBP2 is de-
graded (Fig. 7). One of the changes which occurs to activate
translation of the histone mRNA at oocyte maturation likely
involves removal of SLBP2, followed by association of SLBP1
with the stored histone mRNA. During embryogenesis, there is
a further increase in the amount of histone mRNA translation,
presumably as the rest of the SLBP2 is removed from the
histone mRNA and is replaced by SLBP1.
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